Table of Contents

Vaccines

• Vaccines

  An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial

  Nina Wressnigg, Maikel V. W. van der Velden, Daniel Portsmouth, Wolfgang Draxler, Maria O'Rourke, Peter Richmond, Stephen Hall, William J. H. McBride, Andrew Redfern, John Aaskov, P. Noel Barrett, Gerald Aichinger
• Vaccines

  Immunization with Brucella VirB Proteins Reduces Organ Colonization in Mice through a Th1-Type Immune Response and Elicits a Similar Immune Response in Dogs

  Cora N. Pollak, María Magdalena Wanke, Silvia M. Estein, M. Victoria Delpino, Norma E. Monachesi, Elida A. Comercio, Carlos A. Fossati, Pablo C. Baldi
• Open Access

  Vaccines

  Immunogenicity, Safety, and Antibody Persistence at 3, 5, and 10 Years Postvaccination in Adolescents Randomized to Booster Immunization with a Combined Tetanus, Diphtheria, 5-Component Acellular Pertussis, and Inactivated Poliomyelitis Vaccine Administered with a Hepatitis B Virus Vaccine Concurrently or 1 Month Apart

  Joanne Embree, Barbara Law, Tim Voloshen, Antigona Tomovici
• Vaccines

  Safety and Immunogenicity of an Intranasal Sendai Virus-Based Human Parainfluenza Virus Type 1 Vaccine in 3- to 6-Year-Old Children

  Elisabeth Adderson, Kristen Branum, Robert E. Sealy, Bart G. Jones, Sherri L. Surman, Rhiannon Penkert, Pamela Freiden, Karen S. Slobod, Aditya H. Gaur, Randall T. Hayden, Kim Allison, Nanna Howlett, Jill Utech, Jim Allay, James Knight, Susan Sleep, Michael M. Meagher, Charles J. Russell, Allen Portner, Julia L. Hurwitz
• Vaccines

  Long-Term Immunogenicity of an Inactivated Split-Virion 2009 Pandemic Influenza A H1N1 Virus Vaccine with or without Aluminum Adjuvant in Mice

  Wenting Xu, Mei Zheng, Feng Zhou, Ze Chen
• Vaccines

  Vaccine Self-Assembling Immune Matrix Is a New Delivery Platform That Enhances Immune Responses to Recombinant HBsAg in Mice

  Rafaella F. Q. Grenfell, Lisa M. Shollenberger, E. Farah Samli, Donald A. Harn
• Vaccines

  Protective Immunogenicity of Group A Streptococcal M-Related Proteins

  James B. Dale, Shannon E. Niedermeyer, Tina Agbaosi, Nicholas D. Hysmith, Thomas A. Penfound, Claudia M. Hohn, Matthew Pullen, Michael I. Bright, Daniel S. Murrell, Lori E. Shenep, Harry S. Courtney
• Free

  Vaccines

  Next-Generation Sequencing Reveals a Controlled Immune Response to Zaire Ebola Virus Challenge in Cynomolgus Macaques Immunized with Vesicular Stomatitis Virus Expressing Zaire Ebola Virus Glycoprotein (VSVΔG/EBOVgp)

  Fredrik Barrenas, Richard R. Green, Matthew J. Thomas, G. Lynn Law, Sean C. Proll, Flora Engelmann, Ilhem Messaoudi, Andrea Marzi, Heinz Feldmann, Michael G. Katze